Texas Permanent School Fund’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-28,706
Closed -$964K 640
2024
Q1
$964K Buy
28,706
+517
+2% +$16.6K 0.01% 1325
2023
Q4
$911K Sell
28,189
-335
-1% -$9.35K 0.01% 1324
2023
Q3
$935K Buy
28,524
+2,141
+8% +$74.3K 0.01% 1270
2023
Q2
$928K Sell
26,383
-215
-0.8% -$7.42K 0.01% 1284
2023
Q1
$868K Buy
26,598
+6,659
+33% +$303K 0.01% 1292
2022
Q4
$1.1M Sell
19,939
-1,339
-6% -$73.6K 0.02% 1069
2022
Q3
$942K Buy
21,278
+4,633
+28% +$226K 0.02% 1128
2022
Q2
$812K Buy
16,645
+478
+3% +$21.5K 0.01% 1217
2022
Q1
$787K Sell
16,167
-275
-2% -$11.2K 0.01% 1283
2021
Q4
$701K Buy
+16,442
New +$655K 0.01% 1323

Other funds holding HRMY

Texas Permanent School Fund's HRMY Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Harmony Biosciences (HRMY) in Q2 2024, closing a stake of 28,706 shares — an estimated $964K sold.

Texas Permanent School Fund first reported a position in HRMY in Q4 2021 and held it in 10 quarters. The position peaked at $1.1M in Q4 2022. 219 funds tracked by Wall St. Rank hold HRMY as of Q2 2024.

  • Texas Permanent School Fund reported no remaining Harmony Biosciences position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 28,706 Harmony Biosciences shares in Q2 2024, an estimated $964K.
  • Texas Permanent School Fund first reported a position in Harmony Biosciences in Q4 2021 and held it in 10 quarters.
  • Texas Permanent School Fund's Harmony Biosciences position peaked at $1.1M in Q4 2022.
  • 219 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.